Skip to Main Content

Paper Details

Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer.
Clin Cancer Res
225
2011
0332991, CCND1, CCNE1, CDK4/6, CDK4/6 kinases, CDKN2A, PD-0332991, RB, Rb, Rb-proficiency, Rb-proficient cell lines, human, human ovarian cancer cell lines, ovarian cancer, ovarian cancer cell lines, p16, patients, retinoblastoma
Author NameAffiliation
Gottfried E KonecnyDavid Geffen School of Medicine, University of California los angeles
  • 1 - 1

Datasets

Release 1.2